Brianne Brown, PsyD

Evaluation of Treatment Failure in a Randomized, Open-Label Study of Paliperidone Palmitate Versus Oral Antipsychotics for Recent-Onset Schizophrenia or Schizophreniform Disorder

Background: Despite the availability of effective treatments, outcomes for patients with schizophrenia remain poor. Nonadherence is common early in the disease course, a time when the gre...

Amy O'Donnell , MD, JD, BS;

Ibrahim Turkoz , PhD;

Brianne Brown , PsyD;

Pamela Baker , PharmD;

Larry Alphs , MD, PhD;

10/08/2020

Evaluation of Major Treatment Failures in Patients With Recent-Onset Schizophrenia: A Post Hoc Analysis From the Disease Recovery Evaluation and Modification (DREaM) Study

BACKGROUND: Major treatment failures (MTF), such as psychiatric hospitalization and arrest/incarceration, are associated with substantial economic and societal burden, especially for pers...

Amy O'Donnell , MD, JD, BS;

Ibrahim Turkoz , PhD;

Brianne Brown , PsyD;

Pamela Baker , PharmD;

Larry Alphs , MD, PhD;

10/08/2020

Real-World Safety Profile of Esketamine Nasal Spray During the First 12 Treatment Sessions: An Analysis at 34 Months After Approval

Abstract: Purpose: To examine real-world esketamine nasal spray (ESK) treatment-emergent adverse events (TEAEs) of interest (i.e., sedation, dissociation, increased blood pressure [BP]) a...

Brianne Brown , PsyD;

Elizabeth Daloisio ;

01/19/2023